Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

Manufacturing Facility

Beside our major advancement of the use of mesenchymal stem cells with our platform, we own 53.65% of a subsidiary, ChemOn, non-clinical CRO and GMP facility and it will guarantee the stability of our infrastructure of the whole process of manufacturing stem cell therapy. This tripod support structure will give us the synergistic impact of prosperous our business in this area.
Technology Infrastructure for R&D and Commercialization of Cell-based Medicine